SAM
UTHR icon

Silvercrest Asset Management’s United Therapeutics UTHR Stock Holding History

Silvercrest Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$502K Sell
926
-24
-3% -$13.5K ﹤0.01% 702
2026
Q1 		$563K Sell
950
-695
-42% -$346K ﹤0.01% 669
2025
Q4 		$802K Buy
1,645
+28
+2% +$13K 0.01% 641
2025
Q3 		$678K Buy
1,617
+301
+23% +$101K ﹤0.01% 661
2025
Q2 		$378K Buy
1,316
+153
+13% +$45.7K ﹤0.01% 742
2025
Q1 		$359K Buy
1,163
+186
+19% +$63.7K ﹤0.01% 748
2024
Q4 		$345K Buy
977
+56
+6% +$20.6K ﹤0.01% 742
2024
Q3 		$330K Sell
921
-305
-25% -$103K ﹤0.01% 709
2024
Q2 		$391K Buy
1,226
+32
+3% +$8.47K ﹤0.01% 763
2024
Q1 		$274K Buy
1,194
+14
+1% +$3.16K ﹤0.01% 810
2023
Q4 		$259K Sell
1,180
-14
-1% -$3.23K ﹤0.01% 763
2023
Q3 		$270K Buy
1,194
+43
+4% +$9.9K ﹤0.01% 761
2023
Q2 		$254K Buy
+1,151
New +$255K ﹤0.01% 771
2023
Q1 		– Sell
-832
Closed -$231K – 816
2022
Q4 		$231K Sell
832
-381
-31% -$96.2K ﹤0.01% 740
2022
Q3 		$254K Sell
1,213
-508
-30% -$114K ﹤0.01% 728
2022
Q2 		$406K Sell
1,721
-402
-19% -$81.7K ﹤0.01% 676
2022
Q1 		$381K Buy
2,123
+116
+6% +$22.1K ﹤0.01% 728
2021
Q4 		$434K Buy
+2,007
New +$394K ﹤0.01% 698

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Silvercrest Asset Management's UTHR Position: Q2 2026 in Review

Silvercrest Asset Management reduced its United Therapeutics (UTHR) stake by 2.5% in Q2 2026, selling an estimated $13.5K and leaving 926 shares worth $502K. The position accounts for ﹤0.01% of the portfolio, ranked #702.

Silvercrest Asset Management first reported a position in UTHR in Q4 2021 and has held it in 18 quarters since. The position peaked at $802K in Q4 2025. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Silvercrest Asset Management held 926 shares of United Therapeutics worth $502K as of Q2 2026.
  • Silvercrest Asset Management sold 24 United Therapeutics shares in Q2 2026, an estimated $13.5K.
  • United Therapeutics made up ﹤0.01% of Silvercrest Asset Management's portfolio in Q2 2026, its #702 holding.
  • Silvercrest Asset Management first reported a position in United Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • Silvercrest Asset Management's United Therapeutics position peaked at $802K in Q4 2025.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.